This is a good post, but in terms of the future for investors in Avita, I think the last sentence is the most compelling -
Participating in the ReCell and StrataGraft clinical trials is a prestigious achievement for a Department of Defense facility, because only the best of the best are able to join FDA trials. Chung said he is very proud of the work the ISR has done.
“Between industry and our own research products within the ISR, we will have a solution in the next five to 10 years.”
It seems also that StrataGraft if their preferred option.
I have sold the stock after holding it from the Clinical Cell Culture days.
This is a good post, but in terms of the future for investors in...
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.02 |
Change
0.050(1.68%) |
Mkt cap ! $205.6M | |||
| Open | High | Low | Value | Volume |
| $2.97 | $3.04 | $2.97 | $665.9K | 221.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $3.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.03 | 5341 | 3 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| AVH (ASX) Chart |